Northern Trust’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-264,245
| Closed | -$4.4M | – | 4291 |
|
|
2017
Q3 | $4.4M | Buy |
264,245
+3,449
| +1% | +$56.1K | ﹤0.01% | 2704 |
|
|
2017
Q2 | $4.67M | Sell |
260,796
-17,071
| -6% | -$319K | ﹤0.01% | 2682 |
|
|
2017
Q1 | $5.57M | Buy |
277,867
+11,385
| +4% | +$265K | ﹤0.01% | 2493 |
|
|
2016
Q4 | $6.67M | Buy |
266,482
+22,008
| +9% | +$520K | ﹤0.01% | 2358 |
|
|
2016
Q3 | $5.71M | Buy |
244,474
+7,826
| +3% | +$184K | ﹤0.01% | 2441 |
|
|
2016
Q2 | $4.73M | Sell |
236,648
-2,847
| -1% | -$53.1K | ﹤0.01% | 2504 |
|
|
2016
Q1 | $4.06M | Buy |
239,495
+5,659
| +2% | +$116K | ﹤0.01% | 2533 |
|
|
2015
Q4 | $5.19M | Sell |
233,836
-3,735
| -2% | -$77.8K | ﹤0.01% | 2445 |
|
|
2015
Q3 | $4.03M | Buy |
237,571
+24,797
| +12% | +$386K | ﹤0.01% | 2577 |
|
|
2015
Q2 | $2.92M | Sell |
212,774
-5,941
| -3% | -$78.9K | ﹤0.01% | 2855 |
|
|
2015
Q1 | $2.99M | Sell |
218,715
-979
| -0.4% | -$11.3K | ﹤0.01% | 2851 |
|
|
2014
Q4 | $2.32M | Sell |
219,694
-11,664
| -5% | -$138K | ﹤0.01% | 3007 |
|
|
2014
Q3 | $2.89M | Sell |
231,358
-5,792
| -2% | -$80.8K | ﹤0.01% | 2857 |
|
|
2014
Q2 | $3.24M | Sell |
237,150
-27,587
| -10% | -$361K | ﹤0.01% | 2808 |
|
|
2014
Q1 | $3.2M | Sell |
264,737
-22,195
| -8% | -$254K | ﹤0.01% | 2850 |
|
|
2013
Q4 | $3.53M | Buy |
286,932
+3,852
| +1% | +$45.2K | ﹤0.01% | 2788 |
|
|
2013
Q3 | $2.88M | Sell |
283,080
-5,051
| -2% | -$47.2K | ﹤0.01% | 2875 |
|
|
2013
Q2 | $2.59M | Buy |
+288,131
| New | +$2.9M | ﹤0.01% | 2823 |
|
Northern Trust's OME Position: Q4 2017 in Review
Northern Trust sold out of Omega Protein (OME) in Q4 2017, closing a stake of 264,245 shares — an estimated $4.4M sold.
Northern Trust first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $6.67M in Q4 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Northern Trust reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Northern Trust sold 264,245 Omega Protein shares in Q4 2017, an estimated $4.4M.
- Northern Trust first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Northern Trust's Omega Protein position peaked at $6.67M in Q4 2016.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Northern Trust's 13F filing for Q4 2017, filed 14 Feb 2018.